These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 9577696

  • 21. Physicochemical aspects of urolithiasis.
    Finlayson B.
    Kidney Int; 1978 May; 13(5):344-60. PubMed ID: 351263
    [No Abstract] [Full Text] [Related]

  • 22. Analysis of purines in urinary calculi by high-performance liquid chromatography.
    Safranow K, Machoy Z, Ciechanowski K.
    Anal Biochem; 2000 Nov 15; 286(2):224-30. PubMed ID: 11067744
    [Abstract] [Full Text] [Related]

  • 23. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N, Hergarten S, Hoppe B, Schmidt M, Hesse A.
    J Urol; 2004 Jul 15; 172(1):355-9. PubMed ID: 15201810
    [Abstract] [Full Text] [Related]

  • 24. The effect of a vegetarian and different omnivorous diets on urinary risk factors for uric acid stone formation.
    Siener R, Hesse A.
    Eur J Nutr; 2003 Dec 15; 42(6):332-7. PubMed ID: 14673606
    [Abstract] [Full Text] [Related]

  • 25. [Conservative therapy of urolithiasis].
    Matouschek E, Huber R.
    Arch Esp Urol; 1979 Dec 15; 32(2):91-104. PubMed ID: 464670
    [Abstract] [Full Text] [Related]

  • 26. Local factors compared with systemic factors in the formation of bladder uric acid stones.
    Li WM, Chou YH, Li CC, Liu CC, Huang SP, Wu WJ, Huang CH.
    Urol Int; 2009 Dec 15; 82(1):48-52. PubMed ID: 19172097
    [Abstract] [Full Text] [Related]

  • 27. [Analysis of proteins in urinary tract stones and urine of urolithic patients].
    Yokomizoi K, Nakayama A, Hokazono E, Ninomiya A, Miyake R, Hiratsuka N, Okuyama M, Kato Y, Kobayashi S, Ito Y, Shiba K.
    Rinsho Byori; 2005 Dec 15; 53(12):1109-15. PubMed ID: 16447682
    [Abstract] [Full Text] [Related]

  • 28. [Conservative treatment of urolithiasis in children].
    Gadomska-Prokop K, Konopielko Z.
    Pol Merkur Lekarski; 2000 Apr 15; 8(46):190-3. PubMed ID: 10897607
    [Abstract] [Full Text] [Related]

  • 29. [Effects of diuretic therapy on spontaneous expulsion of urinary calculi, urinary pH, and crystalluria in lithiasic patients].
    Kaid-Omar Z, Belouatek A, Driouch A, Taleb-Bendiab H, Lacour B, Addou A, Daudon M.
    Prog Urol; 2001 Jun 15; 11(3):450-7. PubMed ID: 11512457
    [Abstract] [Full Text] [Related]

  • 30. [Urolithiasis and urinary tract abnormalities in children: own experience].
    Wawro A, Zwolińska D, Miler M, Polak-Jonkisz D, Musiał K.
    Pol Merkur Lekarski; 2000 Apr 15; 8(46):182-4. PubMed ID: 10897603
    [Abstract] [Full Text] [Related]

  • 31. [Identification and quantitation of purine derivatives in urinary calculi as markers of abnormal purine metabolism by using high-performance liquid chromatography (HPLC)].
    Safranow K.
    Ann Acad Med Stetin; 2000 Apr 15; 46():35-49. PubMed ID: 11712316
    [Abstract] [Full Text] [Related]

  • 32. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK, Chow K, Rao PN, Kavanagh JP.
    J Urol; 2007 Jun 15; 177(6):2366-70. PubMed ID: 17509360
    [Abstract] [Full Text] [Related]

  • 33. [Urolithiasis].
    Piasecki Z, Wyczółkowski M.
    Przegl Lek; 1998 Jun 15; 55(9):485-7. PubMed ID: 10085729
    [Abstract] [Full Text] [Related]

  • 34. [24-hour urinary oxalate excretion in healthy children and in children with calcium urolithiasis].
    Sikora P, Bieniaś B, Wawrzyszuk M, Zajaczkowska M.
    Pol Merkur Lekarski; 2008 Jun 15; 24 Suppl 4():76-9. PubMed ID: 18924510
    [Abstract] [Full Text] [Related]

  • 35. [Crystalline structure of urinary stones].
    Trzaska Durski Z, Trzaska Durska H, Kuzaka B.
    Pol Merkur Lekarski; 1999 Dec 15; 7(42):264-6. PubMed ID: 10710950
    [Abstract] [Full Text] [Related]

  • 36. Composition and characteristics of urinary calculi from guinea pigs.
    Hawkins MG, Ruby AL, Drazenovich TL, Westropp JL.
    J Am Vet Med Assoc; 2009 Jan 15; 234(2):214-20. PubMed ID: 19210239
    [Abstract] [Full Text] [Related]

  • 37. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP, Laube N.
    J Urol; 2006 Feb 15; 175(2):766-70. PubMed ID: 16407047
    [Abstract] [Full Text] [Related]

  • 38. Orthophosphate treatment in calcium urolithiasis.
    Smith LH, Werness PG, VanDenBerg CJ, Wilson DM.
    Scand J Urol Nephrol Suppl; 1980 Feb 15; 53():253-63. PubMed ID: 6938002
    [No Abstract] [Full Text] [Related]

  • 39. [Urolithiasis caused by infection].
    Rodríguez Rebollo T, Torres C, Aguilar J, Arrabal M, López C.
    Arch Esp Urol; 1987 May 15; 40(4):263-7. PubMed ID: 3632053
    [No Abstract] [Full Text] [Related]

  • 40. Studies in urolithiasis: Part IV--An electron optical investigation on kinds of crystallization in urinary calculi.
    Rao MV, Agarwal JS.
    Indian J Exp Biol; 1979 Apr 15; 17(4):366-70. PubMed ID: 489064
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.